List of insiders holdings for ENZON PHARMACEUTICALS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | ICAHN CARL C 10% Owner |
2024-12-19 16:30:40 | 36,056,636 0 |
36,056,636 | Form 13D |
2 | COUCHMAN JONATHAN Couchman Family Fund Xstelos Corp. Myrexis Inc. Harper Brian James HARPER ASSET MANAGEMENT LLC Pearce Michael Cooper 10% Owner |
2020-09-17 16:12:32 | 7,851,454 0 |
7,851,454 | Form 13D |
3 | COUCHMAN JONATHAN Couchman Family Fund Xstelos Corp. Myrexis Inc. 10% Owner |
2021-08-17 18:07:15 | 0 7,393,954 |
7,393,954 | Form 4 |
4 | HIGHBRIDGE CAPITAL MANAGEMENT LLC HIGHBRIDGE CAPITAL CORP Highbridge International LLC Dubin Glenn Swieca Henry 10% Owner |
2012-02-14 11:11:39 | 2,293,193 0 |
2,293,193 | Form 13G |
5 | HIGHBRIDGE CAPITAL MANAGEMENT LLC Highbridge International LLC Dubin Glenn Swieca Henry Highbridge Convertible Arbitrage Master Fund L.P. 10% Owner |
2012-02-14 11:11:39 | 2,293,193 0 |
2,293,193 | Form 13G |
6 | BUCHALTER JEFFREY H CEO & President |
2010-01-29 16:59:26 | 529,259 0 |
529,259 | Form 4 |
7 | TOOMAN CRAIG A Exec VP Finance, CFO |
2010-06-22 17:02:34 | 319,680 0 |
319,680 | Form 4 |
8 | HIGGINS ARTHUR J Director |
2004-07-14 15:49:14 | 240,072 0 |
240,072 | Form 4/A |
9 | del Campo Ralph COO and Princ. Exec. Officer |
2011-09-19 19:22:17 | 204,633 0 |
204,633 | Form 4 |
10 | READ RANDOLPH C Director |
2023-06-16 16:05:38 | 200,000 0 |
200,000 | Form 4 |
11 | Levy Harold J Director |
2010-03-10 13:38:19 | 0 166,535 |
166,535 | Form 4 |
12 | HORAK IVAN D EVP, R&D, CSO |
2011-04-05 17:04:23 | 138,476 0 |
138,476 | Form 4 |
13 | Stancic Ana Executive VP, COO, PEO CFO |
2012-01-19 18:48:23 | 125,000 0 |
125,000 | Form 4/A |
14 | HEBARD GEORGE Interim PEO and Interim COO |
2012-11-08 15:47:30 | 116,737 0 |
116,737 | Form 4 |
15 | Davit Paul Stephen Exec. Vice Pres. HR |
2011-07-06 12:28:00 | 109,314 0 |
109,314 | Form 4 |
16 | Bleznick Jordan Director |
2020-11-17 18:11:27 | 100,000 0 |
100,000 | Form 4 |
17 | Buchbinder Aby VP, Clinical Development |
2013-01-25 18:14:59 | 79,246 0 |
79,246 | Form 4 |
18 | Conover Charles SVP, R&D Program Management |
2013-01-25 18:11:23 | 74,793 0 |
74,793 | Form 4 |
19 | ZUERBLIS KENNETH J Executive V.P., Finance, CFO |
2004-06-15 17:32:56 | 60,330 0 |
60,330 | Form 4 |
20 | MICATI VICTOR P Director |
2010-07-06 19:00:16 | 50,625 0 |
50,625 | Form 4 |
21 | GRAU ULRICH M Chief Scientific Officer |
2004-04-05 17:34:57 | 50,000 0 |
50,000 | Form 4 |
22 | Greenberger Lee M VP, Research |
2012-01-19 18:45:13 | 48,146 0 |
48,146 | Form 4 |
23 | ANDO GORAN Director |
2009-07-06 16:52:23 | 43,582 0 |
43,582 | Form 4 |
24 | GOLDE DAVID Director |
2004-07-06 19:51:57 | 3,268 39,100 |
42,368 | Form 4 |
25 | LEBUHN ROBERT Director |
2013-09-19 18:12:57 | 42,189 0 |
42,189 | Form 4 |
26 | DENNER ALEXANDER J Director |
2013-01-04 11:24:39 | 40,258 0 |
40,258 | Form 4 |
27 | Mulligan Richard Director |
2013-01-04 11:26:30 | 35,226 0 |
35,226 | Form 4 |
28 | Renfro Phillip M Director |
2009-01-06 15:08:00 | 33,453 0 |
33,453 | Form 4 |
29 | Geltosky John Director |
2009-01-06 15:07:59 | 33,453 0 |
33,453 | Form 4 |
30 | Rackear Andrew D. CEO and Secretary |
2016-04-05 16:15:22 | 25,000 0 |
25,000 | Form 3 |
31 | Young Richard A Director |
2013-01-04 11:34:57 | 20,129 0 |
20,129 | Form 4 |
32 | Deuel Thomas Director |
2013-01-04 11:33:54 | 20,129 0 |
20,129 | Form 4 |
33 | SALISBURY ROBERT C Director |
2013-01-04 11:27:20 | 20,129 0 |
20,129 | Form 4 |
34 | CLASSON ROLF A Director |
2011-01-05 16:16:47 | 16,996 0 |
16,996 | Form 4 |
35 | DIXON ROSINA B Director |
2006-01-04 17:00:09 | 15,000 0 |
15,000 | Form 4 |
36 | Daly Timothy VP, Controller and PAO |
2012-03-29 15:40:18 | 8,000 0 |
8,000 | Form 4 |
37 | PARKINSON ROBERT L JR Director |
2004-04-01 17:24:56 | 6,738 0 |
6,738 | Form 4 |
38 | Ogden Mark L Acting VP of Fin & Prin FO |
2011-03-01 16:10:02 | 4,000 0 |
4,000 | Form 4 |
39 | BARLOW DAVID S Director |
2004-01-05 15:31:49 | 209 0 |
209 | Form 4 |
40 | FEINSTEIN RICHARD L VP-Finance and PFO |
2013-12-13 18:06:43 | 0 0 |
0 | Form 3 |
41 | CHRISTODORO JONATHAN Director |
2013-10-09 16:40:00 | 0 0 |
0 | Form 3 |
42 | McNealey Jennifer Isacoff Director |
2013-10-07 19:15:55 | 0 0 |
0 | Form 3 |
43 | Kostas Odysseas D Director |
2013-10-07 19:14:17 | 0 0 |
0 | Form 3 |
44 | IRIDIAN ASSET MANAGEMENT LLC 10% Owner |
2013-01-31 09:11:42 | 0 0 |
0 | Form 13G |
45 | Firestone Jaffrey Adam Director |
2022-06-21 16:31:00 | 0 0 |
0 | Form 3 |
46 | WILLS STEPHEN T Director |
2025-01-10 17:01:29 | 0 0 |
0 | Form 3 |